1. (3r)-1-azabicyclo(2.2.2)oct-3-yl 6-((3s,4r)-4-((4-amino-5-chloro-2-methoxybenzoyl)amino)-3-methoxy-1-piperidinyl)hexanoate
2. Ati 7505
3. Ati-7505
4. Ati7505
1. 860174-12-5
2. Ati-7505
3. Naronapride [usan:inn]
4. Naronapride Free Base
5. Ati7505
6. Unii-058896b00b
7. Ati 7505
8. 058896b00b
9. (3r)-1-azabicyclo(2.2.2)oct-3-yl 6-((3s,4r)-4-((4-amino-5-chloro-2-methoxybenzoyl)amino)-3-methoxy-1-piperidinyl)hexanoate
10. 1-piperidinehexanoic Acid, 4-((4-amino-5-chloro-2-methoxybenzoyl)amino)-3-methoxy-, (3r)-1-azabicyclo(2.2.2)oct-3-yl Ester, (3s,4r)-
11. Naronapride [usan]
12. [(3r)-1-azabicyclo[2.2.2]octan-3-yl] 6-[(3s,4r)-4-[(4-amino-5-chloro-2-methoxybenzoyl)amino]-3-methoxypiperidin-1-yl]hexanoate
13. Naronapride [inn]
14. Naronapride (usan/inn)
15. Naronapride [who-dd]
16. Schembl731063
17. Chembl2103858
18. Dtxsid401006590
19. 860174-12-5 (free Base)
20. Db05542
21. Hy-121826
22. Cs-0083508
23. Ns00071036
24. D09933
25. Q27236096
26. (3r)-1-azabicyclo(2.2.2)oct-3-yl 6-((3s,4r)-4-((4-amino-5-chloro-2- Methoxybenzoyl)amino)-3-methoxypiperidin-1-yl)hexanoate
27. (r)-quinuclidin-3-yl 6-((3s,4r)-4-(4-amino-5-chloro-2-methoxybenzamido)-3-methoxypiperidin-1-yl)hexanoate
28. 1-piperidinehexanoic Acid, 4-((4-amino-5-chloro-2-methoxybenzoyl)amino)-3-methoxy-, 1-azabicyclo(2.2.2)oct-3-yl Ester, (3s,4r)-
29. 4-amino-n-(1-{6-[(1-azabicyclo[2.2.2]octan-3-yl)oxy]-6-oxohexyl}-3-methoxypiperidin-4-yl)-5-chloro-2-methoxybenzene-1-carboximidic Acid
1. Naronapride Free Base
2. Ati-7505
3. Cas 860174-12-5
4. Ati 7505
5. 860174-12-5
Molecular Weight | 537.1 g/mol |
---|---|
Molecular Formula | C27H41ClN4O5 |
XLogP3 | 2.8 |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 8 |
Rotatable Bond Count | 12 |
Exact Mass | g/mol |
Monoisotopic Mass | g/mol |
Topological Polar Surface Area | 106 |
Heavy Atom Count | 37 |
Formal Charge | 0 |
Complexity | 752 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 3 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Investigated for use/treatment in gastroesophageal reflux disease (GERD) and gastroparesis.
Serotonin 5-HT4 Receptor Agonists
Endogenous compounds and drugs that specifically stimulate SEROTONIN 5-HT4 RECEPTORS. (See all compounds classified as Serotonin 5-HT4 Receptor Agonists.)
LOOKING FOR A SUPPLIER?